CIK 0001396814
- Large accelerated filer
Pacira BioSciences, Inc.
Sign in to watch- Ticker
- PCRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 510619477
- Phone
- +1 650-242-8052
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
- Former names
- Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $217,920
- in 1 filing, $218K under 10b5-1 plans
Net −$217,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-14 | Riker Lauren Bullaro Senior Vice President, Finance | Grant or award · Stock Option (Right to Buy) 10b5-1 | +25,000 | 25,000 | ||
| 2023-06-14 | Reinhart Charles A. III Chief Financial Officer | Grant or award | +9,000 | 42,626 | ||
| 2023-06-14 | Reinhart Charles A. III Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +22,500 | 22,500 | ||
| 2023-06-14 | PACE GARY W Director | Grant or award | +1,775 | 141,450 | ||
| 2023-06-14 | PACE GARY W Director | Grant or award · Stock Option (Right to Buy) | +12,925 | 12,925 | ||
| 2023-06-14 | Kronenfeld Mark A. Director | Grant or award | +1,775 | 19,672 | ||
| 2023-06-14 | Kronenfeld Mark A. Director | Grant or award · Stock Option (Right to Buy) | +12,925 | 12,925 | ||
| 2023-06-14 | HASTINGS PAUL J Director | Grant or award | +1,775 | 8,374 | ||
| 2023-06-14 | HASTINGS PAUL J Director | Grant or award · Stock Option (Right to Buy) | +12,925 | 12,925 | ||
| 2023-06-14 | GAUGLER DARYL Chief Operating Officer | Grant or award | +10,000 | 31,539 | ||
| 2023-06-14 | GAUGLER DARYL Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2023-06-14 | Froimson Mark Director | Grant or award | +1,775 | 7,843 | ||
| 2023-06-14 | Froimson Mark Director | Grant or award · Stock Option (Right to Buy) | +12,925 | 12,925 | ||
| 2023-06-14 | CHRISTIE CHRISTOPHER Director | Grant or award | +1,775 | 5,261 | ||
| 2023-06-14 | CHRISTIE CHRISTOPHER Director | Grant or award · Stock Option (Right to Buy) | +12,925 | 12,925 | ||
| 2023-06-14 | Brege Laura Director | Grant or award | +1,775 | 11,322 | ||
| 2023-06-14 | Brege Laura Director | Grant or award · Stock Option (Right to Buy) | +12,925 | 12,925 | ||
| 2023-06-08 | Kronenfeld Mark A. Director | Option exercise 10b5-1 | +15,000 | $29.90 | $449K | 32,897 |
| 2023-06-08 | Kronenfeld Mark A. Director | Sale 10b5-1 | −15,000 | $37.04 | $556K | 17,897 |
| 2023-06-08 | Kronenfeld Mark A. Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,000 | 0 |
Page 10 of 23 · 450 trades